Adjunctive Intracoronary Fibrinolytic Therapy During Primary Percutaneous Coronary Intervention
Author:
Funder
British Heart Foundation
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine
Reference77 articles.
1. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomised trials;de Waha;Eur Heart J,2017
2. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction;Henriques;Eur Heart J,2002
3. Coronary microvascular injury in reperfused acute myocardial infarction: a view from an integrative perspective;Sezer;J Am Heart Assoc,2018
4. Coronary microvascular obstruction in acute myocardial infarction;Niccoli;Eur Heart J,2016
5. Thrombus burden and myocardial damage during primary percutaneous coronary intervention;Napodano;Am J Cardiol,2014
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction;Journal of Cardiothoracic Surgery;2024-04-05
2. Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention?;ARYA ATHEROSCLER;2023
3. Effects of early application of heparin on coronary blood flow during primary percutaneous coronary intervention;Tropical Journal of Pharmaceutical Research;2023-09-15
4. Local Intracoronary Fibrinolysis with Distal Occlusion: A Series of Cases Using Marinade Technique;Cardiovascular Revascularization Medicine;2023-08
5. Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial;Frontiers in Cardiovascular Medicine;2021-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3